Company / PP&E (Net)
Steris PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.0B
FY2025
5-year range
$1.2B / $2.0B
FY2021-FY2025
Trend
+10.8%
vs FY2024
Sector context
#28 of 135
Health Care
What the data says
Steris's pp&e (net) of $2.0B is higher than 79% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 7 consecutive years, from $1.0B in FY2018 to $2.0B in FY2025.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of +12.0%. Top quartile in the Health Care sector.
Improved from $1.6B to $2.0B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +12.0%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 135This company $2.0B Sector average $1.4B
▼
+43.6% above sector average
Key checks
Key Insights
- Steris's pp&e (net) has grown for 7 consecutive years.
- 5-year CAGR of +12.0%, indicating consistent growth.
- In FY2025, pp&e (net) increased 10.8% year-over-year.
- Ranks #28 out of 135 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | +10.8% |
| FY2024 | $1.8B | +8.1% |
| FY2023 | $1.6B | +5.2% |
| FY2022 | $1.6B | +25.7% |
| FY2021 | $1.2B | +11.1% |
| FY2020 | $1.1B | +7.8% |
| FY2019 | $1.0B | +2.1% |
| FY2018 | $1.0B | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 13, 2026